Results 271 to 280 of about 530,197 (354)
A CASE OF UNSYNCHRONOUS MULTIPLE CANCER OF THE ESOPHAGUS AND THE BLADDER
, 1979 Yoshitaka Nakata +8 more
openalex +2 more sources
Engineered Hydrogels Revolutionize Locoregional Cancer Immunotherapy
Advanced NanoBiomed Research, EarlyView.This review systematically summarizes the latest research progress on injectable hydrogels in cancer immunotherapy, highlighting their unique advantages in precise immune activation, local drug‐controlled release, and immune microenvironment remodeling. These features provide innovative solutions to overcome the bottlenecks of systemic side effects and
Jiyong Wei +3 more
wiley +1 more source
Immunotherapeutic strategies for invasive bladder cancer: a comprehensive review. [PDF]
Front ImmunolWang Y, He M, Li J, Li L.
europepmc +1 more source
Advanced NanoBiomed Research, EarlyView.Biomimetic microdevices are redefining anticancer drug screening by mimicking complex tumor microenvironments. This review highlights advances in microfluidic systems, cell microarrays, and in vivo‐like models, offering new insights into drug efficacy prediction and personalized medicine. The development of effective anticancer drugs remains a critical
Ching‐Te Kuo +2 more
wiley +1 more source
Exploring bladder cancer through urinary microbiota: innovative "urinetypes" classification and establishment of a diagnostic model. [PDF]
J Transl MedSheng Z +12 more
europepmc +1 more source
Emerging Strategies for Platelet‐Modified Nanoparticles in Targeted Tumor Therapy
Advanced NanoBiomed Research, EarlyView.This review highlights innovative strategies using platelet‐modified nanoparticles to target tumors more precisely. By mimicking platelet functions, these biomimetic carriers improve tumor homing, enhance drug delivery, and reduce immune clearance.
Chunyu Bai +5 more
wiley +1 more source
CENPF overexpression in bladder cancer cells enhances proliferation, migration, invasion, and apoptosis. [PDF]
Sci RepSong R +8 more
europepmc +1 more source